Human Trials of Stem Cell-Derived Dopamine Neurons for Parkinson's Disease: Dawn of a New Era.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 29100010.
- Also identified by DOI 10.1016/j.stem.2017.09.014.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Stem cell-based therapies for Parkinson's disease are moving into a new and exciting era, with several groups pursuing clinical trials with pluripotent stem cell (PSC)-derived dopamine neurons. As many groups have ongoing or completed GMP-level cell manufacturing, we highlight key clinical translation considerations from our recent fourth GForce-PD meeting.
Medical subject headings
- Clinical Trials as Topic
- Dopaminergic Neurons
- Parkinson Disease
- Stem Cell Transplantation